{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:27:41Z","timestamp":1782512861647,"version":"3.54.5"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,7,5]],"date-time":"2012-07-05T00:00:00Z","timestamp":1341446400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Parasitol Res"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s00436-012-3019-2","type":"journal-article","created":{"date-parts":[[2012,7,5]],"date-time":"2012-07-05T02:38:00Z","timestamp":1341455880000},"page":"2473-2477","source":"Crossref","is-referenced-by-count":24,"title":["Antiamoebic properties of the actinomycete metabolites echinomycin A and tirandamycin A"],"prefix":"10.1007","volume":"111","author":[{"given":"Avelina","family":"Espinosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron M.","family":"Socha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Ryke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Rowley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,7,5]]},"reference":[{"key":"3019_CR1","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1128\/CMR.00019-06","volume":"20","author":"V Ali","year":"2007","unstructured":"Ali V, Nozaki T (2007) Current therapeutics, their problems, and sulfur-containing-amino-acid metabolism as a novel target against infections by \u201camitochondriate\u201d protozoan parasites. Clin Microbiol Rev 20:164\u2013187","journal-title":"Clin Microbiol Rev"},{"key":"3019_CR2","doi-asserted-by":"crossref","first-page":"507","DOI":"10.4269\/ajtmh.1983.32.507","volume":"32","author":"CJ Austin","year":"1983","unstructured":"Austin CJ, Warren LG (1983) Induced division synchrony in Entamoeba histolytica. Effects of hydroxyurea and serum deprivation. Am J Trop Med Hyg 32:507\u2013511","journal-title":"Am J Trop Med Hyg"},{"key":"3019_CR3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1383-5742(02)00007-8","volume":"511","author":"A Bendesky","year":"2002","unstructured":"Bendesky A, Menendez D, Ostrosky-Wegman P (2002) Is metronidazole carcinogenic? Mutat Res 511:133\u2013144","journal-title":"Mutat Res"},{"key":"3019_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ja.2005.1","volume":"58","author":"J B\u00e9rdy","year":"2005","unstructured":"B\u00e9rdy J (2005) Bioactive microbial metabolites. J Antibiot 58:1\u201326","journal-title":"J Antibiot"},{"key":"3019_CR5","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1128\/JCM.37.6.1771-1776.1999","volume":"37","author":"H Ceri","year":"1999","unstructured":"Ceri H, Olson ME, Stremick C, Read RR, Morck DW, Buret A (1999) The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 37:1771\u20131776","journal-title":"J Clin Microbiol"},{"key":"3019_CR6","first-page":"1","volume-title":"Waterborne zoonoses: identification, causes and control","year":"2004","unstructured":"Cotruvo JA, Dufour A, Rees G, Bartram J, Carr R, Cliver DO, Craun GF, Fayer R, Gannon VPJ (eds) (2004) Waterborne zoonoses: identification, causes and control. World Health Organization with IWA Publishing, London, pp 1\u2013528"},{"key":"3019_CR7","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1128\/AAC.47.4.1407-1409.2003","volume":"47","author":"AL Crowell","year":"2003","unstructured":"Crowell AL, Sanders-Lewis KA, Secor WE (2003) In vitro metronidazole and tinidazole activities against metronidazole-resistant strains of Trichomonas vaginalis. Antimicrob Agents Chemother 47:1407\u20131409","journal-title":"Antimicrob Agents Chemother"},{"key":"3019_CR8","doi-asserted-by":"crossref","first-page":"20136","DOI":"10.1074\/jbc.M101349200","volume":"276","author":"A Espinosa","year":"2001","unstructured":"Espinosa A, Yan L, Zhang ZL, Foster L, Clark D, Li E, Stanley SL Jr (2001) The bifunctional Entamoeba histolytica alcohol dehydrogenase 2 (EhADH2) protein is necessary for amoebic growth and survival and requires an intact C-terminal domain for both alcohol dehydrogenase and acetaldehyde dehydrogenase activity. J Biol Chem 276:20136\u201320143","journal-title":"J Biol Chem"},{"key":"3019_CR9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/jac\/dkh280","volume":"54","author":"A Espinosa","year":"2004","unstructured":"Espinosa A, Clark D, Stanley SL Jr (2004) Entamoeba histolytica alcohol dehydrogenase 2 (EhADH2) as a target for anti-amoebic agents. J Antimicrob Chemother 54:56\u201359","journal-title":"J Antimicrob Chemother"},{"key":"3019_CR10","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/jac\/dkp015","volume":"63","author":"A Espinosa","year":"2009","unstructured":"Espinosa A, Perdrizet G, Paz-y-Mi\u00f1o-C G, Lanfrachi R, Phay M (2009) Effects of iron depletion on Entamoeba histolytica alcohol dehydrogenase 2 (EhADH2) and trophozoite growth: implications for antiamoebic therapy. J Antimicrob Chemother 63:675\u2013678","journal-title":"J Antimicrob Chemother"},{"key":"3019_CR11","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/nchembio841","volume":"2","author":"W Fenical","year":"2006","unstructured":"Fenical W, Jensen PR (2006) Developing a new resource for drug discovery: marine actinomycete bacteria. Nat Chem Biol 2:666\u2013673","journal-title":"Nat Chem Biol"},{"key":"3019_CR12","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJMra022710","volume":"348","author":"R Haque","year":"2003","unstructured":"Haque R, Huston CD, Hughes M, Houpt E, Petri WA (2003) Amebiasis. N Engl J Med 348:1565\u20131573","journal-title":"N Engl J Med"},{"key":"3019_CR13","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.mpmed.2009.08.001","volume":"37","author":"JM Kenny","year":"2009","unstructured":"Kenny JM, Kelly P (2009) Protozoal gastrointestinal infections. Medicine 37:599\u2013602","journal-title":"Medicine"},{"key":"3019_CR14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.diagmicrobio.2004.06.014","volume":"50","author":"KL LaPlante","year":"2004","unstructured":"LaPlante KL, Rybak MJ (2004) Clinical glycopeptide-intermediate staphylococci tested against arbekacin, daptomycin, and tigecycline. Diagn Microbiol Infect Dis 50:125\u2013130","journal-title":"Diagn Microbiol Infect Dis"},{"key":"3019_CR15","doi-asserted-by":"crossref","first-page":"408","DOI":"10.7164\/antibiotics.33.408","volume":"33","author":"VJ Lee","year":"1980","unstructured":"Lee VJ, Rinehart KL Jr (1980) C NMR spectra of streptolydigin, tirandamycin, and related degradation products. J Antibiot 33:408\u2013415","journal-title":"J Antibiot"},{"key":"3019_CR16","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.1021\/ja00748a067","volume":"93","author":"FA MacKellar","year":"1971","unstructured":"MacKellar FA, Grostic MF, Olson EC, Wnuk RJ (1971) Tirandamycin. I. Structure assignment. J Am Chem Soc 93:4943\u20134945","journal-title":"J Am Chem Soc"},{"key":"3019_CR17","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1128\/AEM.70.3.1593-1599.2004","volume":"70","author":"C Matz","year":"2004","unstructured":"Matz C, Deines P, Boenigk J, Arndt H, Eberl L, Kjelleberg S, J\u00fcrgens K (2004) Effect of violacein-producing bacteria on survival and feeding of bacterivorous nanoflagellates. Appl Environ Microbiol 70:1593\u20131599","journal-title":"Appl Environ Microbiol"},{"key":"3019_CR18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/nar\/gkh166","volume":"32","author":"LG May","year":"2004","unstructured":"May LG, Madine MA, Waring MJ (2004) Echinomycin inhibits chromosomal DNA replication and embryonic development in vertebrates. Nucleic Acids Res 32:65\u201372","journal-title":"Nucleic Acids Res"},{"key":"3019_CR19","doi-asserted-by":"crossref","first-page":"558","DOI":"10.7164\/antibiotics.24.558","volume":"24","author":"CE Meyer","year":"1971","unstructured":"Meyer CE (1971) Tirandamycin, a new antibiotic isolation and characterization. J Antibiot 24:558\u2013560","journal-title":"J Antibiot"},{"key":"3019_CR20","doi-asserted-by":"crossref","first-page":"897","DOI":"10.2307\/3277502","volume":"56","author":"LK Ong","year":"1970","unstructured":"Ong LK, Wolfson N (1970) Some growth characteristics of axenically cultivated Entamoeba histolytica-like amebae (Huff strain). J Parasitol 56:897\u2013903","journal-title":"J Parasitol"},{"key":"3019_CR21","first-page":"105","volume":"8","author":"T Osato","year":"1955","unstructured":"Osato T, Ueda M, Fukuyama S, Yagishita K, Okami Y, Umezawa H (1955) Production of tertiomycin (a new antibiotic substance), azomycin and eurocidin by S. eurocidicus. J Antibiot 8:105\u2013109","journal-title":"J Antibiot"},{"key":"3019_CR22","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/ja.2008.52","volume":"61","author":"K Otoguro","year":"2008","unstructured":"Otoguro K, Ishiyama A, Namatame M, Nishihara A, Furusawa T, Masuma R, Shiomi K, Takahashi Y, Yamada H, Omura S (2008) Selective and potent in vitro antitrypanosomal activities of ten microbial metabolites. J Antibiot 61:372\u2013378","journal-title":"J Antibiot"},{"key":"3019_CR23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/jac\/dkm421","volume":"61","author":"Y Park","year":"2008","unstructured":"Park Y, Shin W, Kim S (2008) In vitro and in vivo activities of echinomycin against clinical isolates of Staphylococcus aureus. J Antimicrob Chemother 61:163\u2013168","journal-title":"J Antimicrob Chemother"},{"key":"3019_CR24","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.4065\/83.10.1154","volume":"83","author":"BS Pritt","year":"2008","unstructured":"Pritt BS, Clark CG (2008) Amebiasis. Mayo Clin Proc 83:1154\u20131159","journal-title":"Mayo Clin Proc"},{"key":"3019_CR25","doi-asserted-by":"crossref","first-page":"e2335","DOI":"10.1371\/journal.pone.0002335","volume":"3","author":"J Prudhomme","year":"2008","unstructured":"Prudhomme J, McDaniel E, Ponts N, Bertani S, Fenical W, Le Roch K (2008) Marine actinomycetes: a new source of compounds against the human malaria parasite. PLoS One 3:e2335","journal-title":"PLoS One"},{"key":"3019_CR26","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1128\/AAC.10.4.618","volume":"10","author":"F Reusser","year":"1976","unstructured":"Reusser F (1976) Tirandamycin, an inhibitor of bacterial ribonucleic acid polymerase. Antimicrob Agents Chemother 10:618\u2013622","journal-title":"Antimicrob Agents Chemother"},{"key":"3019_CR27","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1021\/np070126a","volume":"70","author":"AM Socha","year":"2007","unstructured":"Socha AM, Long RA, Rowley DC (2007) Bacillamides from a hypersaline microbial mat bacterium. J Nat Prod 70:1793\u20131795","journal-title":"J Nat Prod"},{"key":"3019_CR28","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.bmcl.2009.01.010","volume":"19","author":"AM Socha","year":"2009","unstructured":"Socha AM, LaPlante KL, Russell DJ, Rowley DC (2009) Structure\u2014activity studies of echinomycin antibiotics against drug-resistant and biofilm-forming Staphylococcus aureus and Enterococcus faecalis. Bioorg Med Chem Lett 19:1504\u20131507","journal-title":"Bioorg Med Chem Lett"},{"key":"3019_CR29","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0140-6736(03)12830-9","volume":"361","author":"SL Stanley Jr","year":"2003","unstructured":"Stanley SL Jr (2003) Amoebiasis. Lancet 361:1025\u20131034","journal-title":"Lancet"},{"key":"3019_CR30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00248-007-9320-4","volume":"56","author":"J Thelaus","year":"2008","unstructured":"Thelaus J, Forsman M, Andersson A (2008) Role of productivity and protozoan abundance for the occurrence of predation-resistant bacteria in aquatic systems. Microb Ecol 56:18\u201328","journal-title":"Microb Ecol"},{"key":"3019_CR31","unstructured":"Walsh JA (1986) Amebiasis in the world. Arch Invest Med 17:385\u2013359"},{"key":"3019_CR32","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/252653a0","volume":"252","author":"MJ Waring","year":"1974","unstructured":"Waring MJ, Wakelin LP (1974) Echinomycin: a bifunctional intercalating antibiotic. Nature 252:653\u2013657","journal-title":"Nature"},{"key":"3019_CR33","doi-asserted-by":"crossref","first-page":"26051","DOI":"10.1074\/jbc.274.37.26051","volume":"274","author":"C Wassmann","year":"1999","unstructured":"Wassmann C, Hellberg A, Tannich E, Bruchhaus I (1999) Metronidazole resistance in the protozoan parasite Entamoeba histolytica is associated with increased expression of iron-containing superoxide dismutase and peroxiredoxin and decreased expression of ferredoxin 1 and flavin reductase. J Biol Chem 274:26051\u201326056","journal-title":"J Biol Chem"},{"key":"3019_CR34","doi-asserted-by":"crossref","unstructured":"Xim\u00e9nez C, Mor\u00e1n P, Rojas L, Valadez A, G\u00f3mez A (2009) Reassessment of the epidemiology of amebiasis: state of the art. Infect Genet Evol 9:1023\u20131032","DOI":"10.1016\/j.meegid.2009.06.008"},{"issue":"8","key":"3019_CR35","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1021\/ol200420u","volume":"13","author":"Z Yu","year":"2011","unstructured":"Yu Z, Vodanovic-Jankovic S, Ledeboer N, Huang S, Rajski SR, Kron M, Shen B (2011) Tirandamycins from Streptomyces sp. 17944 inhibiting the parasite Brugia malayi asparagine tRNA synthetase. Org Lett 13:2034\u20132037","journal-title":"Org Lett"}],"container-title":["Parasitology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-012-3019-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00436-012-3019-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-012-3019-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T07:19:41Z","timestamp":1594365581000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00436-012-3019-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,5]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["3019"],"URL":"https:\/\/doi.org\/10.1007\/s00436-012-3019-2","relation":{},"ISSN":["0932-0113","1432-1955"],"issn-type":[{"value":"0932-0113","type":"print"},{"value":"1432-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,5]]}}}